Gurleen Dhami1, Jing Zeng1, Hubert J Vesselle2, Paul E Kinahan2, Robert S Miyaoka2, Shilpen A Patel1, Ramesh Rengan1, Stephen R Bowen3,4. 1. Department of Radiation Oncology, University of Washington School of Medicine, 98195, Seattle, WA, USA. 2. Department of Radiology, University of Washington School of Medicine, 98195, Seattle, WA, USA. 3. Department of Radiation Oncology, University of Washington School of Medicine, 98195, Seattle, WA, USA. srbowen@uw.edu. 4. Department of Radiology, University of Washington School of Medicine, 98195, Seattle, WA, USA. srbowen@uw.edu.
Abstract
PURPOSE: To design and apply a framework for predicting symptomatic radiation pneumonitis in patients undergoing thoracic radiation, using both pretreatment anatomic and perfused lung dose-volume parameters. MATERIALS AND METHODS: Radiation treatment planning CT scans were coregistered with pretreatment [99mTc]MAA perfusion SPECT/CT scans of 20 patients who underwent definitive thoracic radiation. Clinical radiation pneumonitis was defined as grade ≥ 2 (CTCAE v4 grading system). Anatomic lung dose-volume parameters were collected from the treatment planning scans. Perfusion dose-volume parameters were calculated from pretreatment SPECT/CT scans. Equivalent doses in 2 Gy per fraction were calculated in the lung to account for differences in treatment regimens and spatial variations in lung dose (EQD2lung). RESULTS: Anatomic lung dosimetric parameters (MLD) and functional lung dosimetric parameters (pMLD70%) were identified as candidate predictors of grade ≥ 2 radiation pneumonitis (AUC > 0.93, p < 0.01). Pairing of an anatomic and functional dosimetric parameter (e. g., MLD and pMLD70%) may further improve prediction accuracy. Not all individuals with high anatomic lung dose (MLD > 13.6 GyEQD2lung, 19.3 Gy for patients receiving 60 Gy in 30 fractions) developed radiation pneumonitis, but all individuals who also had high mean dose to perfused lung (pMLD70% > 13.3 GyEQD2) developed radiation pneumonitis. CONCLUSIONS: The preliminary application of this framework revealed differences between anatomic and perfused lung dosimetry in this limited patient cohort. The addition of perfused lung parameters may help risk stratify patients for radiation pneumonitis, especially in treatment plans with high anatomic mean lung dose. Further investigations are warranted.
PURPOSE: To design and apply a framework for predicting symptomatic radiation pneumonitis in patients undergoing thoracic radiation, using both pretreatment anatomic and perfused lung dose-volume parameters. MATERIALS AND METHODS: Radiation treatment planning CT scans were coregistered with pretreatment [99mTc]MAA perfusion SPECT/CT scans of 20 patients who underwent definitive thoracic radiation. Clinical radiation pneumonitis was defined as grade ≥ 2 (CTCAE v4 grading system). Anatomic lung dose-volume parameters were collected from the treatment planning scans. Perfusion dose-volume parameters were calculated from pretreatment SPECT/CT scans. Equivalent doses in 2 Gy per fraction were calculated in the lung to account for differences in treatment regimens and spatial variations in lung dose (EQD2lung). RESULTS: Anatomic lung dosimetric parameters (MLD) and functional lung dosimetric parameters (pMLD70%) were identified as candidate predictors of grade ≥ 2 radiation pneumonitis (AUC > 0.93, p < 0.01). Pairing of an anatomic and functional dosimetric parameter (e. g., MLD and pMLD70%) may further improve prediction accuracy. Not all individuals with high anatomic lung dose (MLD > 13.6 GyEQD2lung, 19.3 Gy for patients receiving 60 Gy in 30 fractions) developed radiation pneumonitis, but all individuals who also had high mean dose to perfused lung (pMLD70% > 13.3 GyEQD2) developed radiation pneumonitis. CONCLUSIONS: The preliminary application of this framework revealed differences between anatomic and perfused lung dosimetry in this limited patient cohort. The addition of perfused lung parameters may help risk stratify patients for radiation pneumonitis, especially in treatment plans with high anatomic mean lung dose. Further investigations are warranted.
Authors: Mike E Robbins; Judy K Brunso-Bechtold; Ann M Peiffer; Christina I Tsien; Janet E Bailey; Lawrence B Marks Journal: Radiat Res Date: 2012-02-21 Impact factor: 2.841
Authors: David A Palma; Suresh Senan; Kayoko Tsujino; Robert B Barriger; Ramesh Rengan; Marta Moreno; Jeffrey D Bradley; Tae Hyun Kim; Sara Ramella; Lawrence B Marks; Luigi De Petris; Larry Stitt; George Rodrigues Journal: Int J Radiat Oncol Biol Phys Date: 2012-06-09 Impact factor: 7.038
Authors: Shankar Siva; Thomas Devereux; David L Ball; Michael P MacManus; Nicholas Hardcastle; Tomas Kron; Mathias Bressel; Farshad Foroudi; Nikki Plumridge; Daniel Steinfort; Mark Shaw; Jason Callahan; Rodney J Hicks; Michael S Hofman Journal: Technol Cancer Res Treat Date: 2015-01-09
Authors: L B Marks; D P Spencer; G W Sherouse; G Bentel; R Clough; K Vann; R Jaszczak; R E Coleman; L R Prosnitz Journal: Int J Radiat Oncol Biol Phys Date: 1995-08-30 Impact factor: 7.038
Authors: Katherina P Farr; Jesper F Kallehauge; Ditte S Møller; Azza A Khalil; Stine Kramer; Henrik Bluhme; Anni Morsing; Cai Grau Journal: Radiother Oncol Date: 2015-08-21 Impact factor: 6.280
Authors: Nina-Sophie Hegemann; Rebecca Koepple; Franziska Walter; David Boeckle; Wolfgang P Fendler; Martin Kurt Angele; Stefan Boeck; Claus Belka; Falk Roeder Journal: Strahlenther Onkol Date: 2018-01-18 Impact factor: 3.621
Authors: Faegheh S Mounessi; Jörg Eckardt; Arne Holstein; Santiago Ewig; Stefan Könemann Journal: Strahlenther Onkol Date: 2019-10-02 Impact factor: 3.621
Authors: Eunsin Lee; Jing Zeng; Robert S Miyaoka; Jatinder Saini; Paul E Kinahan; George A Sandison; Tony Wong; Hubert J Vesselle; Ramesh Rengan; Stephen R Bowen Journal: Med Phys Date: 2017-06-01 Impact factor: 4.071
Authors: K J Borm; M Oechsner; K Schiller; J C Peeken; H Dapper; S Münch; L Kroll; S E Combs; M N Duma Journal: Strahlenther Onkol Date: 2018-07-16 Impact factor: 3.621
Authors: Hannah Mary T Thomas; Jing Zeng; Howard J Lee; Balu Krishna Sasidharan; Paul E Kinahan; Robert S Miyaoka; Hubert J Vesselle; Ramesh Rengan; Stephen R Bowen Journal: Br J Radiol Date: 2019-08-12 Impact factor: 3.039